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Abstract
Background: The Janus kinase (Jak) and signaling transducer activator of transcription (Stat) pathway mediates the
signaling of genes required for cellular development and homeostasis. To elucidate the effect of type I IFN on the
Jak/stat pathway in salmonid alphavirus subtype 3 (SAV3) infected macrophage/dendritic like TO-cells derived from
Atlantic salmon (Salmo salar L) headkidney leukocytes, we used a differential transcriptome analysis by RNA-seq and
the Kyoto encyclopedia of genes and genomes (KEGGs) pathway analysis to generate a repertoire of de novo
assembled genes from type I IFN treated and non-treated TO-cells infected with SAV3.
Results: Concurrent SAV3 infection with type I IFN treatment of TO-cells suppressed SAV3 structural protein (SP)
expression by 2log10 at 2 days post infection compared to SAV3 infection without IFN treatment which paved way
to evaluating the impact of type I IFN on expression of Jak/stat pathway genes in SAV3 infected TO-cells. In the
absence of type I IFN treatment, SAV3 downregulated several Jak/stat pathway genes that included type I and II
receptor genes, Jak2, tyrosine kinase 2 (Tyk2), Stat3 and Stat5 pointing to possible failure to activate the Jak/stat
signaling pathway and inhibition of signal transducers caused by SAV3 infection. Although the suppressor of
cytokine signaling (SOCS) genes 1 and 3 were upregulated in the IFN treated cells, only SOCS3 was downregulated
in the SAV3 infected cells which points to inhibition of SOCS3 by SAV3 infection in TO-cells.
Conclusion: Data presented in this study shows that SAV3 infection downregulates several genes of the Jak/stat
pathway, which could be an immune evasion strategy, used to block the transcription of antiviral genes that would
interfere with SAV3 replication in TO-cells. Overall, we have shown that combining de novo assembly with pathway
based transcriptome analyses provides a contextual approach to understanding the molecular networks of genes
that form the Jak/stat pathway in TO-cells infected by SAV3.
Background
The Jak/stat pathway has been shown to contribute posi-
tively to innate immune responses against viral infections
from drosophila to vertebrates [1–3]. Viruses have evolved
counter measures that block different components of the
Jak/stat pathway to prevent production of antiviral
compounds [3, 4]. While very little information is available
for salmon pancreas disease virus (SPDV also referred to
as salmon alphavirus - SAV) causing pancreas disease of
Atlantic salmon (Salmo salar L) and trout (Oncorhynchus
mykiss), it has been shown that other alphaviruses like chi-
kungunya virus (ChikV) inhibit the stimulation type I and
II IFN by blocking Jak/stat signaling, likely through NSP2
[1, 3]. Lin et al. [5] showed that Japanese encephalitis virus
(JEV) block IFN induced Jak/stat signaling through a pro-
tein tyrosine phosphatase mediated mechanism. As pointed
out by Fujii et al. [6] that strategies of counteracting Jak/stat
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signaling vary among viruses which include suppressing the
phosphorylation of the Jaks, inhibition of nuclear transloca-
tion of activated Stats, degradation of different Jak/stat
components as well as inducing the expression of negative
regulators such as the SOCS proteins by host cells. This
shows that viruses alter the Jak/stat signaling at different
stages of the pathway.
Janus kinase (Jak) and signaling transducer and activator
of transcription (Stat) is an intracellular signaling pathway
that mediates the effects of a large number of cytokines
and growth factors [7]. It is a pleiotropic cascade used to
transduce a network of signals for the development and
homeostasis of cells from vertebrates to insects. Jak activa-
tion stimulates cell proliferation, differentiation, migration
and apoptosis. In general, the Jak/stat pathway is based on
a few principle components involving a variety of ligands
and their receptors [8]. Intracellular activation of the Jaks
takes places when ligand binding induces dimerization of
receptor subunits on cell surfaces [8]. For signal transduc-
tion through dimerization, the cytoplasmic domain of the
receptor subunits must be associated with Jak tyrosine
kinases, which juxtaposes the Jaks to allow for their trans-
phosphorylation. The transphophorylated Jaks phosphor-
ylate additional targets that include the Stats. Stats are
latent transcriptional factors found in the cytoplasm in an
inactive state until they are activated. Phosphorylated Stats
migrate to the nucleus where they modulate the transcrip-
tion of different target genes. In general, the Jak/stat
pathway provides a direct mechanism in which extracellu-
lar signals are translated into transcriptional responses
that modulate the expression of different target genes.
Apart from Stats, other effector molecules that contrib-
ute to Jak/stat signaling include the signal-transducing
adaptor molecules (STAMs) that facilitate the transcrip-
tional activity of specific target genes such as transcrip-
tional regulator Myc (Myc) [9] and the stat-interacting
protein (StlP) which serves as a scaffold to phosphorylate
the Stats by the Jaks [8]. On the other hand, three major
classes of negative regulators have been identified which
include the suppressor of cytokine signaling (SOCS), pro-
tein inhibitors of activated stats (PIAS) and protein tyro-
sine phosphates (PTPs) [10]. The SOCS family serves as a
negative feedback loop on the Jak/stat circuit in which ac-
tivated Stats stimulate the transcription of SOCS genes
that bind to phosphorylated Jaks and their receptors to
turn off the signaling pathway [11, 12]. The PTPs includes
the SHP-2 phosphatases, which has two SH2 (src-hom-
ology-2) domains that bind to the Jaks to initiate the de-
phosphorylation of the Jak and Stat proteins [13]. The
PIAS proteins bind to activated Stat dimers to prevent
their signal transducing activities although the exact
mechanism in which this is carried out has not been
established [13, 14]. Put together, the Jak/stat cascade is a
tightly controlled pathway regulated by different effector
proteins and negative regulators that prevent overstimula-
tion of the paracrine pathway.
Therefore, to identify genes that alter Jak/stat signaling
induced by viral infections calls for a comprehensive
profiling of genes induced by virus replication during in-
fection progression in host cells. In the present study we
used RNA-seq and put together a de novo assembly of
genes belonging to the Jak/stat pathway induced by
salmonid alphavirus subtype-3 (SAV-3) infection in TO-
cells. TO-cells are a continuous cell-line derived from
Atlantic salmon headkidney leukocytes characterized to
possess dendritic cell-like properties [15]. SAV3 is a po-
tent inducer of type I IFN responses in TO-cells while at
the same time, the virus replicates vividly under high
IFN I levels [15–17]. Pretreatment of permissive cells
with recombinant salmon IFN I will protect the cells
against CPE but the effect of this treatment will depend
on time of treatment relative to infection [17]. The
mechanisms employed by SAV3 to circumvent or block
the antiviral responses of the host cells are not known.
Hence, in this study we wanted to identify the profile of
genes linked to the Jak/stat pathway induced by SAV3
infection in TO-cells and to compare their expression
patterns in cells simultaneously infected with SAV3 and
treated with type I IFN to SAV3-only infected cells. The
aim was to understand any modulation of the antiviral
responses elicited by SAV3 infection compared to partly
protected (IFN I/SAV3) cells. To do this, we used the
Kyoto encyclopedia of genes and genomes (KEGG) data-
base analysis to generate pathways of differentially
expressed genes generated by de novo assembly using
RNA-seq from SAV3 infected TO-cells. In general, we
anticipate that data presented here shall serve as a road-
map to elucidating the cellular networks linked to the
Jak/stat pathway used by SAV3 to evade the host defen-
sins in infected fish.
Methods
Cell culture, virus infection and IFN treatment
TO-cells derived from Atlantic salmon (Salmo salar L) head
kidney leukocytes characterized to possess macrophage/den-
dritic-like properties were use in this study [15, 16]. The
TO-cells, were propagated in HMEM (Eagle’s minimal es-
sential medium [MEM] with Hanks’ balanced salt solution
[BSS]) supplemented with L-glutamine, MEM nonessential
amino acids, gentamicin sulfate, 10 % FBS and were incu-
bated at 20 °C. The Salmon alphavirus subtype 3 (Genebank
accession JQ799139) used to inoculate the TO-cells has pre-
viously been described [18]. One batch of TO-cells was
treated with 500 ng/ml of Atlantic salmon Type I IFN in
triplicates and was simultaneously infected with SAV3.
Another batch of TO-cells was only infected with SAV-3,
without type I IFN treatment. The virus was inoculated at
an MOI 1 when the cells were 80 % confluent in both
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groups. Thereafter, both the SAV-3 infected cells with and
without IFN treatment were incubated at 15 °C in mainten-
ance media using HMEM growth media supplemented with
2 % FBS. The mock group was only treated with mainten-
ance media without SAV3 infection and no type I IFN treat-
ment. Cells were harvested after 48 h and were used for
RNA extraction used for RNA-seq analysis. Another set of
three independent replicates subjected to the same treat-
ment was used for qRT-PCR analysis. All studies in TO-
cells were carried out in triplicates.
RNA isolation
Extraction of total RNA was carried out using the RNeasy
mini Kit with on-column DNase treatment according to
the manufacturer’s instructions (Qiagen, Hilden, Germany).
The concentration and quality of RNA was analyzed
using a Nanodrop ND1000 (Nanodrop Technologies,
Wilmington, USA) and Agilent 2100 Bioanalyzer (Agi-
lent Technologies, USA), respectively.
Library construction, sequencing and data analysis for
RNA-Seq
Triplicates of equal quantities of total RNA from IFN-
treated and non-treated-TO-cells infected with SAV3 to-
gether with Mock cells were mixed to prepare the
pooled RNA sample for each group. The pooled samples
were treated with DNase I for the degradation of any
possible DNA contamination followed by enrichment
using oligo(dT) magnetic beads. Thereafter, the mRNA
was fragmented into short fragments of approximately
200 bp by mixing with the fragmentation buffer. This
was followed by first strand cDNA synthesis using ran-
dom hexamer-primer, which was followed by adding a
buffer containing dNTPs, RNase H and DNA polymer-
ase I to synthesize the second strand. The generated
double strand cDNA was then purified with magnetic
beads and the end reparation and 3’-end single nucleo-
tide A (adenine) addition was then performed. There-
after, sequence adaptors were ligated to the fragments,
which were later enriched by PCR amplification. The
Agilent 2100 Bioanaylzer and ABI StepOnePlus Real-
Time PCR System (Biorad.com) were used to qualify
and quantify the sample library during quality check
(QC step). After the QC step, library products were
ready for RNA-sequencing using Illumina HiSeqTM
2000, BGI-Hong Kong. For RNA-seq analysis, clean reads
were obtained after removal of adaptor sequences, reads
having greater than 10 % unknown bases as well as re-
moval of low quality bases (base with quality value ≤ 5)
greater than 50 % in a read.
Functional annotation and gene ontology classification
Raw reads generated by illumina sequencing were used
to generate a library of clean reads after quality check,
which was used for transcriptome de novo assembly
using the Trinity software (http://trinityrnaseq.github.io
[19]. Thereafter, assembled unigenes were used for anno-
tation for the classification of gene functions by searching
different protein databasesusing BlastX version 2.2.23 as
previously described [18]. Data from BlastX was used to
extract the coding regions (CDS) from unigene sequences
and translate them into peptide sequences. As for uni-
genes without hits in BlastX, the ESTScan was used to
predict their CDS and to decide their sequence direction.
Unigenes having NR annotation were further analyzed
with Blast2go (https://www.blast2go.com/) to obtain their
gene ontology (GO) annotations for classification accord-
ing to GO functions using the Web Gene Ontology
(WEGO) annotation software.
Identification of differentially expressed genes and KEGG
pathway analysis
Identification of differentially expressed genes (DEGs)
was carried out as previously described [18]. In this
study, DEGs were generated based on comparing the
RPKM mapped reads from TO cells treated with type I
IFN simultaneously infected with SAV3 versus mock
TO-cells that were designated as TO-VS-IFN/SAV3,
while the second comparison was based on TO-cell in-
fected with SAV-3 only, without IFN treatment, versus
mock TO-cells that were designated as TO-VS-SAV3.
Only genes with a threshold of false discovery rate
(FDR) <0.001 and an absolute value log2ratio > 1 were
considered as differentially expressed. Thereafter, all
DEGs were assigned KEGG orthologue (KO) identifiers
which were later used for pathway analysis using
the KEGG database (http://www.genome.jp/kegg/). In
addition, we used the TIGR gene indices clustering tools
(TGICL) (http://www.tigr.org/tdb/tgi) [19, 20] software
to remove redundancy.
Validation of RNA-Seq Data by qRT-PCR
To confirm the validity of the DEGs generated by RNA-
Seq, 13 DEGs obtained from the TO-VS-IFN/SAV3 and
TO-VS-SAV3 were randomly selected for the qRT-PCR
validation test. Gene expression of three independent
replicates of TO-cells simultaneously treated with type I
IFN and infected with SAV-3 (TO-VS-IFN/SAV3) was
compared with none-type I IFN treated cells infected
with SAV3 (TO-VS-SAV3) relative to gene expression of
untreated TO-cells before normalized to β-actin. Cells
used for independent replicate biological testing were in-
dependent of the cells used for RNA-seq data analysis.
The qRT-PCR was carried out as previously described
[18] using 100 ng total RNA as a template for each gene
in a master-Mix final volume of 25 μl according to
manufacturer’s recommendations (Roche Diagnostics,
Mannheim, Germany). Primers used in the study are
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shown in Table 1 and the primer-master-mix solutions
were first incubated for reverse transcription at 50 °C for
10 min followed by PCR initial activation at 95 °C for
5 min and 40 amplification cycles (10 s at 95 °C and 30 s
at 60 °C). The specificity of each PCR products was
confirmed by melting-curve analysis and agarose gel
electrophoresis. The delta Ct method was used to calcu-
late the fold-increase in gene expression relative to the
β-actin control group [21]. All quantifications were nor-
malized to β-actin control group. The qRT-PCR was
done thrice, with each repeat study having three inde-
pendent replicates of IFN treated (TO-VS-IFN/SAV3)
and non-treated cells (TO-VS-SAV3). The mean of each
gene from the three independent replicates after three
repeats was used to compute the correlation coefficient
test between RNA-seq and qRT-PCR data.
Virus quantification
In order to determine the effect of type I IFN treatment on
SAV3 replication in TO-cells, virus quantification was de-
termined after 48 hrs replication at 15 °C for the IFNα
treated and non-treated groups using a guided sequence
format for the structural proteins (SPs) and non-structural
proteins (NSPs) of SAV3 (GeneBank accession nos.
AFJ15605.1 and AF15604.1) based on the RNA-seq data.
The Fragment per kilobase per million (FPRM) method
was used to read the number of fragments of NSPs and SPs
expressed by SAV3 after 48 hrs replication at 15 °C in the
IFNα treated and non-treated cells. In order to verify the
validity of the virus quantification data generated by RNA-
Seq, quantitative RT-PCR (qRT-PCR) was used to deter-
mine the SAV3 replication level in the IFNα treated and
non-treated cells using the E2 SP expressed during SAV3
replication. The primer sequences used for E2 quantifica-
tion are shown in Table 1 and the qRT-PCR method used
has previously been described by Xu et al. [17].
Result
Virus quantification
First we documented the effect of IFN I treatment on
the SAV3 SP (structural protein) expression. We found
that the non-IFNα treated cells had 102 higher expres-
sion levels of SAV3 SPs than the IFN I treated cells
(Table 2). This shows that simultaneous treatment with
IFN I reduced the level of synthesis of mRNA SPs from
subgenomic viral RNA. Similarly, the NSP mRNAs
(non-structural proteins mRNAs) expressed in the non-
IFNα treated cells were 100.8 higher than in the IFNα
treated group (IFN/SAV3). The log2 ratio of the IFN-
plusSAV3/SAV3 for the SPs and NSPs showed a down-
regulation of -7.4092 and -2.3219, respectively, showing
that type I IFN added concurrently with SAV-3 infection
significantly reduced virus replication in TO cells
(Table 2). Consistent with RNA-seq data shown in
Table 2, Fig. 1 shows a 20 fold-reduction in SAV3 repli-
cation in the IFN I treated cells (IFN/SAV3) relative to
the untreated cells based on the E2 SPs detected by
qPCR using the Cp-value test. Thus, qPCR confirms the
validity of our RNA-seq data analysis by showing that a
downregulation of SAV3 SPs in IFN I treated cells (IFN/
SAV3) versus SAV3 infected cells only.
Functional annotation based on the KEGG pathway
analysis
Based on data generated by illumina sequencing, we
constructed three libraries that yielded a total of 23 331
Table 1 Primer sequencing for qRT-PCR
Primer name Sequence GeneBank
accession no
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788, 24 608 338 and 23 421 631 raw reads for the IFN-
treated and non-IFN treated TO-cells infected with
SAV3 together with mock TO-cells, respectively. The
total unique match in total mapped reads was >90 %
after removal of redundancy using the TGICL software
(http://www.tigr.org/tdb/tgi) suggesting low redundancy.
After quality check for clean reads and filtration [18],
20,115 unigenes from the TO-VS-IFN/SAV3 and TO-
SV-SAV3 groups assigned to the KEGG orthologues
(KO) were identified using the KEGG database (http://
www.genome.ad.jp/kegg/), which has been widely used
to generate pathway networks for model organisms such
as the Zebra fish (Danio rerio) [22, 23] and mouse (Mus
musculus) [24] as well as several non-model organisms
[25, 26]. The profile of genes identified using KO-based
on the RPKM method in which only genes with an FDR
< 0.001 and an absolute value log2ratio > 1 were consid-
ered differentially expressed showed that the TO-VS-
IFN/SAV3 had 1629 DEGs whose KOs were mapped to
237 pathways of which 49 DEGs belonged the Jak/stat
pathway (Table 3). On the other hand, the TO-VS-SAV3
had a total of 9135 DEGs assigned to KO-identifiers,
which was 7506 DEGs more than the TO-VS-IFN/SAV3.
As a result, the TO-VS-SAV3 had 252 pathways identi-
fied by the KEGG database being 15 pathways more than
those identified in the TO-VS-IFN/SAV3 (Table 3). In
terms of Jak/stat genes, the TO-VS-SAV3 had a total of
135 DEGs expressed being 86 DEGs more than the TO-
VS-IFN/SAV3. In general, the TO-VS-SAV3 had more
DEGs and pathways identified using the KEGG data-
base analysis than the TO-VS-IFN/SAV3 although the
TO-VS-IFN/SAV3 had a higher enrichment Qvalue
(1.136E-06, p value = 8.07E-08) than the TO-VS-SAV3
(5.899E-01, p value = 8.07E-01) (Table 3).
To gain more insights on the impact of type I IFN
treatment on the Jak/stat pathway in TO-cells infected
with SAV-3, we compared the DEGs expressed from the
TO-VS-IFN/SAV3 with DEGs from the TO-VS-SAV3.
Figure 2 shows that of the 135 DEGs expressed in the
TO-VS-SAV3, 119 DEGs were downregulated while 16
were upregulated. In the TO-VS-IFN/SAV3 group 40
DEGs were upregulated while 9 DEGs were downregu-
lated. Put together, these findings show that the propor-
tion of upregulated DEGs in the TO-VS-IFN/SAV3
(81.6 %, n = 49) was higher than in the TO-SV-SAV3
group (11.9 %, n = 135) while the proportion of downregu-
lated DEGs for the TO-SV-SAV3 (88.1 %, n = 135) was
higher than the TO-VS-IFN/SAV3 group (18.4 %, n = 49).
This is strongly suggesting that type I IFNs upregulate sev-
eral genes of the Jak/stat pathway that were downregu-
lated by SAV3 infection alone in TO-cells. Hence, to
further elucidate the type of genes suppressed by SAV3 in-
fection in the absence of type I IFN treatment, we broadly
classified the DEGs in the Jak/stat pathways for both the
TO-VS-IFN/SAV3 and TO-VS-SAV3 into type I and II
receptor genes, Jaks, Stats and negative regulator genes as
shown below.
Type I and II receptor genes
Differentially expressed genes belonging to receptor li-
gands that activate the Jak/stat pathway were classified
into type I and II receptor-genes. As shown in Fig. 2 and
Table 3, the type I receptor family was subdivided into the
gamma chain (γC), gp130 and single chain (homodimer)
receptor genes while the type II receptor family comprised
of type I and II IFN receptor genes. The major difference
Table 2 Comparison structural and non-structural protein






Gene ID AFJ15605.1 AFJ15604.1
Gene length 3960 7764
Expression of SAV3 1800842.81 62.71
Expression of SAV3 (log10) 1 × 106.26 1 × 101.80
Expression of IFN/SAV3 9403.57 11.43
Expression of IFN/SAV3 (log10) 1 × 103.97 1 × 101.06
SAV3-FPKM 42259.47 0.75
IFN/SAV3-FPKM 248.61 0.15




Fig. 1 Shows virus titration based on detection of the E2 structural
protein for SAV3 by the ΔΔCp-value analytical method at 48 hours
after inoculation in TO-cells. Simultaneous treatment of IFNα and SAV3
infection (TO-VS-IFN/SAV3) reduced the replication of the virus by 20
fold relative to SAV3 infected TO-cells (TO-VS-SAV3) without
IFNα treatment
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between the TO-VS-IFN/SAV3 and TO-VS-SAV3 ob-
served is that interleukin (IL) 13RA, IL-6RA, and Growth
factor receptor-bound protein 2 (GRB2) were only down-
regulated in the TO-VS-SAV3 while IL-4RA and IL-15R
were only upregulated in the TO-VS-IFN/SAV3. In gen-
eral, there were more type I receptor genes differentially
expressed in the TO-VS-SAV3 than in the TO-VS-IFN/
SAV3 (Fig. 3) of which most of them were downregulated
(Table 4).
The type II receptor genes were subdivided into two
groups namely the interleukin (IL) and IFN receptor
genes. As shown in Table 3, the IL-receptor genes com-
prised of IL-10RB and IL-20RA of which both were up-
regulated in the TO-VS-IFN/SAV3 and TO-VS-SAV3.
The IFN-receptor genes comprised of IFN-α/β and IFNγ
receptor genes (Table 4). The IFN-α/β receptor genes
comprised of IFNR1 and IFNR2 which were upregulated
in both the TO-VS-SAV3 and TO-VS-IFN/SAV3 while
the IFNγ receptor genes comprised of IFNGR1 and
IFNGR2 that were only expressed in the TO-VS-IFN/
SAV3 in which both were upregulated (Table 4). Fig. 4
shows a schematic layout of the common IFN-receptor
signaling pathways based on mammalian model species
[8, 27] of which applying data presented in Table 3
shows that the IFN-receptor-genes expressed by the TO-
VS-IFN/SAV3 were linked to both pathways A and B
while the IFN-receptor-genes expressed by the TO-VS-
SAV3 was only linked to pathway A.
Janus and tyrosine kinase genes
Three genes belonging to the Jaks were differentially
expressed namely Jak1, Jak2 and tyrosine kinase (Tyk2)
(Fig. 3, Table 5). All three Jaks were differentially
expressed in the TO-VS-SAV3 while only Jak1 was dif-
ferentially expressed in the TO-VS-IFN/SAV3. Jak1 was
upregulated in both the TO-VS-SAV3 and TO-VS-IFN/
SAV3 while Jak2 and Tyk2 were downregulated in the
TO-VS-SAV3 (Table 5). Network pathways linking the
Jaks to other genes in the Jak/stat pathway are shown in
Fig. 5A for the TO-VS-IFN/SAV3 and in Fig. 4B for TO-
VS-SAV3. Note that Fig. 5A shows upregulation of all
Jaks being in conformity with observations made in
Table 5 in which only Jak1 was differentially expressed
in the TO-VS-IFN/SAV3 and it was upregulated. On the
other hand, Fig. 5B shows a mixed representation of up-
regulated and downregulated Jak-genes, which is in
agreement with observations shown in Table 4 in which
Jak1 was upregulated whiles Jak2 and Tyk2 were
downregulated.
Signal transducer and activator of transcription genes
Five Stat genes were differentially expressed in this study
namely Stats 1, 2, 3, 5B and 6 (Table 5). As shown in
Fig. 2A, Stats 1, 2, 3 and 5B were differentially expressed
in the TO-VS-SAV3 of which Stats 1 and 2 were upregu-
lated while Stats 3 and 5B were downregulated (Table 5).
In the TO-VS-IFN/SAV3, Stats 1, 2 and 6 were upregu-
lated (Table 5, Fig. 3B). The network links of the Stats to
other genes in the Jak/stat pathway for the TO-VS-SAV3
and TO-VS-IFN/SAV3 are shown in Fig. 5A and B, re-
spectively. Note that all Stats in the TO-VS-IFN/SAV3
were upregulated in Fig. 5A conforming to observations
shown in Table 5 in which all Stats were upregulated
while Fig. 5B shows a mixed representation of upregu-
lated and downregulated Stats for the TO-VS-SAV3 be-
ing in line with observation shown in Table 4 in which
Stats 1 and 2 were upregulated while Stats 3 and 5B
were downregulated.
Negative regulatory genes
The negative regulatory genes for the Jak/stat pathway
differentially expressed in this study were classified into
Table 3 Comparison of TO-VS-IFN/SAV3 and TO-VS-SAV3
Parameters TO-VS-IFN/SAV3 TO-VS-SAV3
KEGG orthology unigenes (KO) 20,115 20,115
Differentially expressed genes (DEGs) 1629 9,135
Total JAKSTAT DEGs 49 135
Upregulated DEGs 40 16
Down regulated DEGs 9 119
Number of KEGG pathways 237 252
JAKSTAT pathway Qvalue 1.14E-06 5.90E-01
JAKSTAT pathway p-value 8.07E-08 8.07E-01
Fig. 2 Comparison of downregulated and upregulated differentially
expressed genes (DEGs) induced in TO-cells infected by SAV3 without
type I FN treatment (TO-VS-SAV3) and type I IFN treated cells infected
with SAV3 (TO-VS-IFN/SAV3)
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the suppressor of cytokine signaling (SOCS) and the
protein inhibitor of activation of stat (PIAS) genes (Fig. 3
and Table 5). Table 5 shows that SOCS1 and SOCS3
were both upregulated in the TO-VS-IFN/SAV3 while
SOCS3 was downregulated and SOCS1 was upregulated
in the TO-VS-SAV3. Figure 5A and B shows network
pathways linking the SOCS to other genes in the Jak/stat
pathway in which all SOCSs were upregulated in the
TO-VS-IFN/SAV3 (Fig. 5A), which conforms to observa-
tions shown in Table 4. The network pathway in the
TO-VS- SAV3 shows a mixed representation of upregu-
lated and downregulated SOCSs (Fig. 5B), which con-
forms to observations shown in Table 5 where SOCS1
was upregulated while SOCS3 was downregulated in the
TO-VS-SAV3. As for PIAS, it was downregulated in the
TO-VS-SAV3 and upregulated in the TO-VS-IFN/SAV3
(Fig. 5A and B).
Apoptosis and cell proliferation genes
Genes that regulate apoptosis and cell-cycle activities
were broadly classified into the Stat, MAPK and PI3K-
AKT pathways as shown in Table 6 based on network
pathways shown in Fig. 5A and B. In the Stat-pathway,
the IFN regulatory factor 9 (IRF), creb binding protein
(CBP) and threonine-protein kinase pim-1 (Pim-1) were
upregulated in the TO-VS-IFN/SAV3 while in the TO-
VS-SAV3, the signal transducer and adaptor molecule 2
(STAM2), CBP, Pim-1 and Pim-3 were downregulated
(Table 6). In the MAPK pathway shown in Fig. 5A and
B, the transcriptional regulator Myc-2 (Myc-2) and
cyclin D (CycD1) were upregulated in the TO-VS-IFN/
SAV3 while the Src homology region 2 domain-
containing phosphatase-2 (SHP2) which is represented
by the protein tyrosine phosphatase non-receptor 11
(PTPN11) in Table 5, son of sevenless (SOS), Myc-2,
Fig. 3 Schematic presentation of the Jak/stat pathway genes induced by SAV-3 infection without type I IFN treatment (TO-VS-SAV3) and type I IFN treated
cells (TO-VS-IFN/SAV3) infected with SAV3. Note each group is subdivided into type I and II receptors, Jak and tyrosine kinases, negative regulators and
signal transducers. a shows that the TO-VS-SAV3 had more type I receptor than the TO-VS-IFN/SAV3 shown in b. Among the type II receptors, the
IFNGR1 and IFNGR2 were only reported in the TO-VS-IFN/SAV3 and not in the TO-VS-SAV3 while among the Jaks, Tyk2 was only expressed in the
TO-VS-SAV3 and not in TO-VS-IFN/SAV3. For the signal transducer, Stat5B was only expressed in the TO-VS-SAV3 and not in the TO-VS-IFN/SAV3 while
Stat6 was only expressed in the TO-VS-IFN/SAV3 and not in the TO-VS-SAV3
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Table 4 Type I and II receptor genes
Gene name Abbr Unigene NCBI KEGG TO-VS-SAV3 TO-VS-SAV+IFN
Log2 (Fold change) Reg P-value Log2 (Fold change) Reg P-value
Type I cytokine and noncytokine receptors
(i) Gamma chain (YC) family
Interleukin-2 receptor beta chain IL-2RB Unig32859 NP_001134020.1 K05069 6.56 Up 1.52e-02 9.68 Up 3.89e-16
Interleukin-4 receptor alpha chain IL-4RA CL1700.1 NP_001133565.1 K05071 1.04 Up 4.17e-24
Interleukin-13 receptor alpha chain IL-13RA Unig8578 NP_001133641.1 K05076 -1.89 Down 1.06e-71
Interleukin-15 receptor alpha chain IL-15RA Unig15594 NP_001118044.1 K05074 1.29 Up 5.72e-09
(ii) gp130 family
Interleukin-6 signal transducer GP130 IL-6RA Unig10219 CBL94873.1 K05060 -1.05 Down 7.91e-05
Interleukin-12 receptor beta chain IL-12RB CL7886.1 XP_003452899.1 K05064 -1.91 Down 6.32e-52 -1.35 Down 2.74e-22
Leptin receptor LEPR CL10577.1 NP_001158237.1 K05062 -2.57 Down 2.00e-5 -1.77 Down 5.00e-4
Leukemia inhibitory factor receptor alpha LIFRA Unig7438 ADV36655.1 K05080 -1.92 Down 5.58e-168 -1.36 Down 4.60e-94
(iii) Single chain family
Growth hormone receptor isoform 1 GHR1 Unig15500 NP_001117048.1 K05080 -2.17 Down 5.74e-27 -1.05 Down 4.78e-08
Growth factor receptor-bound protein 2 GRB2 Unig8178 XP_003455002.1 K04364 -1.16 Down 3.05e-25
Type II cytokine receptors
(i) IFN family receptor
Interferon receptor 1 IFNAR1 Unig34816 K05130 1.86 Up 3.24e-03 3.47 Up 9.38e-08
Interferon receptor 2 IFNAR2 Unig11244 K05131 1.23 Up 2.97e-11 2.58 Up 1.07e-65
Interferon-gamma receptor 1 IFNGR1 CL9561.2 ABY87188.1 K05132 1.14 Up 1.55e-124
Interferon-gamma receptor 2 IFNGR2 CL3893.1 ABY87189.1 K05133 1.57 Up 2.44e-140
(ii) Interleukin receptors
Interleukin-10 receptor beta chain IL-10RB Unig6317 ACI67546.1 K05135 3.78 Up 2.11e-04 4.92 Up 4.2e-05













CycD, B-cell lymphoma extra-large (BclXL) and
Sprouty-related EVH1 domain-containing protein 1 (S-
pred) were all downregulated in the TO-VS-SAV3
(Table 6 and Fig. 5B). The phosphatidylinositol-4,5-
bisphosphate 3-kinase (PI3K) and V-akt viral oncogene
2-like protein (AKT2) that regulate the PI3K-AKT-
pathway for apoptosis were downregulated in TO-VS-
SAV3 (Table 6) while only PI3K was downregulated in
the TO-VS-IFN/SAV3. Network pathways linking the
apoptosis and cell cycle genes for the TO-VS-SAV3 and
TO-VS-IFN/SAV3 are shown in Fig. 5A and B. In gen-
eral, all apoptosis and cell proliferation genes differen-
tially expressed in the TO-VS-SAV3 were downregulated
while the majority differentially expressed in the TO-VS-
IFN/SAV3 was upregulated indicating that in the ab-
sence of type I IFN treatment SAV3 suppressed the ex-
pression of most of anti-apoptosis and cell proliferation
genes.
Validation of RNA-Seq data by qRT-PCR
Figure 6 shows validation of RNA-seq data based correl-
ation coefficient test between RNA-seq and qRT-PCR
data. Our findings show a significantly high linear cor-
relation (r2 = 0.8832, P < 0.0001) between RNA-seq and
qRT-PCR for the TO-VS-IFN/SAV3 and TO-VS-SAV3.
Put together, qRT-PCR confirms the validity of our
RNA-seq data analysis by showing a high correlation be-
tween RNA-seq and qRT-PCR.
Discussion
De novo and reference gene guided transcriptome
assembly
Current advances in next generation sequencing show
that RNA-seq is poised to enhance our understanding of
molecular networks of genes that form the innate and
adaptive immune system in teleosts fish. In general,
there are two approaches used to assemble a transcrip-
tome from RNA-seq data which is by use of a de novo
assembly or a reference gene guided approach. In situa-
tions where no reference gene exists as is the case for
non-model organisms like Atlantic salmon, a de novo as-
sembly is the only option for sequence assembly by
which raw reads from RNA-seq are assembled into con-
tigs without the guidance of a reference gene. Hence, in
the present study we used a de novo approach to assem-
ble a repertoire of genes that form the Jak/stat pathway
from Atlantic salmon headkidney/macrophage like TO-
cells with an aim to understand SAV3 modulation of
Fig. 4 Shows the schematic presentation of the IFN-α/β and IFNγ receptors linked to the Jaks for the TO-VS-IFN/SAV3 and TO-VS-SAV3. In pathway A, the
IFN-α/β binds Jak1 and Tyk2 receptor subunits linked to Stats 1 and 2, followed by a pathway that translocates the phophorylated Stats into nucleus. In
pathway B, the IFNγ receptor is shown to bind to Jaks 1 and 2, which are linked to Stat1 and the phosphorylated Stats are shown to translocate to the
nucleus. Based on data shown in Table 2, the TO-VS-IFN/SAV3 uses both pathways A and B using the IFN-α/β and IFNγ ligands while the TO-VS-SAV3 only
uses pathway A using the IFN-α/β ligand. This model is adapted from IFN-receptor signaling pathways for the Jak/stat pathway in higher
vertebrates [41, 42, 70]
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Table 5 Repertoire of Jak kinuses signal transducer and activator of transcription, and negative regulatory genes
Gene name Abbr Unigene NCBI KEGG TO-VS-SAV3 TO-VS- IFN/SAV3
Log2 (Fold change) Reg P-value Log2(Fold Change) Reg P-value
A: Jaks
Tyrosine-protein kinase JAK1 JAK1 CL2001.7 NP_571148 K11217 1.17 Up 1.87e-185 2.61 Up 1.01e-05
Janus kinase 2 JAK2 Unig38863 ACU12481 K04447 -1.97 Down 3.84e-05
Tyrosine kinase 2 TyK2 Unig6068 ACU12483.1 K11219 -1.07 Down 7.70e-27
B: Signal transducers
Signal transducer and activator of transcription 1 STAT1 CL2066.1 NP_001134757.1 K11220 6.03 Up 3.06e-68 7.11 Up 1.20e-4
Signal transducer and activator of transcription 2 STAT2 Unig6362 NP_001138896.1 K11221 1.88 Up 1.31e-06 2.67 Up 1.10e-4
Signal transducer and activator of transcription 3 STAT3 CL10061.2 GU933429.1 K04692 -1.32 Down 4.00e-05
Signal transducer and activator of transcription 5B STAT5 Unig39041 XP_003454096.1 K11224 -2.32 Down 3.00e-05
Signal transducer and activator of transcription 6 STAT6 Unig2573 ACU12488.1 K11225 1.29 Up 3.83e-57
C: Negative loop feedback
Suppressor of cytokine signaling 3 SOCS3 Unig14487 NP_001139640.1 K04696 -1.25 Down 1.02e-07 1.89 Up 1.04e-07
Suppressor of cytokine signaling 1 SOCS1 Unig8629 CCC15083.1 K04694 6.86 Up 1.31e-207 7.78 Up 1.11e-04













responses post infection. Unlike microarray that uses
predefined probes, de novo assembly provides a unique
opportunity to identify novel genes which could be
missed by none-coded micro-RNA probes. After de novo
assembly, we used the TGICL software, which is a highly
refined protocol used for the analysis of genes and EST
sequences needed for transcriptome analysis [20]. Using
this software, sequences are first cleaned to remove
adaptors, low quality sequences without quality score,
vector and adaptor contaminants and redundancies.
Thereafter, sequences are searched pairwise and grouped
into clusters that are assembled at high stringency to
produce tentative concesus (TC) sequences. And as
pointed out by Pertea et al. [19], individual assembly of
each cluster to produce TCs has the advantage of produ-
cing large, more concensus sequences while eliminating
potentially misclustered sequences. The TCs produced
by the TGICL software have been used to construct
Fig. 5 Shows Jak/stat pathway analysis for the TO-VS-IFN/SAV3 and TO-VS-SAV3 using the KEGG pathway software analysis. a shows the Jak/stat network
pathway for the TO-VS-IFN/SAV3 while b shows the Jak/statcnetwork pathway of the TO-VS-SAV3. Red square depicts upregulated genes while the green
square show the downregulated genes in the pathway. A mixed shading of red/green squares represents a mixed population of upregulated and down-
regulated genes. Note that there were more downregulated genes in the TO-VS-SAV3 (Fig. 5A) than in the TO-VS-IFN/SAV3 (Fig. 5B)
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Table 6 Apoptosis and cell proliferation target genes
Gene name Abbr Unigenes NCBI KEGG TO-VS-SAV3 TO-VS-IFN/SAV3
Log2 (Fold change) Reg P-value Log2 (Fold change) Reg P-value
A: Stat pathway genes
Signal transducing adaptor molecule 2 STAM2 CL86.2 NP_001007370.1 K04705 -1.51 Down 1.76e-12
Interferon regulatory factor 9 IRF9 CL11337.2 NP_001167190.1 K04693 1.65 Up 1.26e-13
CREB binding protein CBP CL7696.2 AAY85296.1 K04498 -2.67 Down 1.14e-06
Threonine-protein kinase pim-1-like Pim-1 CL9459.2 XP_003449193.1 K04702 -1.11 Down 2.38e-55 1.07 Up 5.80e-90
Threonine-protein kinase pim-3-like Pim-3 CL1163.1 XP_003445092.1 K08807 -1.63 Down 9.75e-179
B: MAPK Signaling pathway
Protein tyrosine phosphatase, non-receptor 11 PTPN11 Unig19725 XP_003965393.1 K07293 -2.25 Down 2.21e-3
Son of sevenless homolog 1 SOS1 CL9403.1 XP_003216158.1 K03099 -2.66 Down 3.28e-10 -1.06 Down 1.17e-3
Son of sevenless homolog 2 SOS2 Unig28623 XP_003443018.1 K03099 -2.57 Down 5.88e-07
Transcriptional regulator Myc-2 Myc-2 Unig13199 NP_001167287.1 K04377 -2.16 Down 3.244e-07 1.11 Up 1.03e-05
G1/S-specific cyclin-D1 CycD1 CL11123.1 NP_001158863.1 K04503 -1.33 Down 3.33e-05
G1/S-specific cyclin-D2 CycD2 CL3895.1 ACO14329.1 K10151 -2.23 Down 1.35e-168
Apoptosis regulator Bcl-X BcIXL CL2019.1 ACI68003.1 K04070 -1.30 Down 1.21e-38
Sprouty-related, EVH1 domain containing Sprouty CL10970.1 XP_003456564.1 K04703 -1.84 Down 7.73e-62
C: PI3K-AKT pathway
Akt RAC-beta serine/threonine-protein kinase AKT CL4020.1 ACY30363.1 K04456 -1.59 Down 3.83e-16
Phosphatidylinositol-4,5-bisphosphate 3-kinase PIK3CA Unig30697 NP_998471.1 K00922 -1.64 Down 2.0e-5 -1.21 Down 4.84e-3
D: Other genes













species specific databases and to identify novel genes
[20]. For example, several genes such as STAM2, SOS,
and PIAS not previously reported from Atlantic salmon
were matched to their orthologues in model species such
as zebrafish and mammalia in this study suggesting that
the Jak/stat pathway induced in macrophage/dendritic
cell like TO-cells derived from Atlantic salmon headkid-
ney cells expresses a repertoire of genes comparable to
the Jak/stat signaling pathway observed in higher verte-
brate species. On the other hand, we used a reference
gene guided approach to detect and quantify the E2 SP
of SAV3 based on the fact that the genomic sequence of
SAV3 has been fully sequenced and characterized in sal-
monids [17, 28, 29]. Hence, both the de novo and refer-
ence gene guided assemblies were used in this study.
Virus quantification in IFN I treated and non-treated
TO-cells infected with SAV3
Virus replication in TO-cells of simultaneous IFN I/
SAV3 treatment/infection (IFN/SAV3) was two logs
(102) lower than levels detected in SAV3-only infected
cells. For the latter, it shows that SAV3 is a potent in-
ducer of IFN signaling pathways in TO-cells post infec-
tion and also that the virus had the capacity to replicate
in the presence of high levels of type I IFNs and timing
of IFN I treatment is crucial [18]. These findings are
consistent with observations made for other alphavirus
studies in which it has been shown that timing in type I
IFN treatment has a significant influence on replication
of alphaviruses in infected cells [1, 30, 31].
KEGG pathway analysis
RNA-seq is perfect for gene network construction and
pathway analysis [32]. And as pointed out by Khatri et
al. [33], pathway analysis has become the first choice to
understand the underlying biological mechanisms of
DEGs because it reduces the complexicity of RNA-seq
data analysis whose vast array of sequence data is often
difficult to interpret but instead combining RNA-seq
with pathway analysis increases the explanatory power
of transcriptome data analysis. In pathway analysis the
first step is to generate a transcriptome of DEGs as
shown in this study followed by searching for functional
networks of genes expressed in the transcriptome based
on the fact that there is a tendency for co-regulated
genes to have functional correlations in the pathway.
Khatri et al. [33] shown that pathway software develop-
ment has progress through three different generations in
the last decade. The first generation of pathway analyt-
ical softwares comprise of the over-representation ana-
lysis (ORA) softwares that include GenMAPP (http://
www.genmapp.org), GOstat (http://gostat.wehi.edu.au)
and GOToolBox (http://genome.crg.es/GOToolBox/).
These software establish pathway analysis by putting to-
gether over expressed genes that show significant changes
in expression based on gene level statistic [34, 35]. The
second generation of softwares consist of functional class
Fig. 6 Shows a significantly high linear correlation (r2 = 0.8832, P< 0.0001) between RNA-seq and quantitative real time PCR (qRT-PCR) data for the TO-VS-
IFN/SAV3 and TO-VS-SAV3. Dotted lines show the 95 % confidence limits for the correlation coefficient (r2) slope (95 % CI 0.8478 - 0.9771). qPCR data was
generated as the mean of the fold increase in gene expression relative to the β-actin control group from three independent replicates (N= 3) of TO-cells
simultaneously treated with type I IFN and infected with SAV3 (TO-VS-IFN/SAV3) together with none-IFN treated cells infected with SAV3 (TO-VS-SAV3). The
cells used in this study were independent of cells used for RNA-seq data analysis
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scoring (FCS) approaches such as the Gene Set Enrichment
Analysis (GSEA) software (http://www.broadinstitute.org/
gsea/) and GeneTrail (http://genetrail.bioinf.uni-sb.de) that
compute both the statistical significance of individual genes
that form a pathway (gene level statistic) and the statistical
significance of the entire pathway (pathway level statistic)
[36–38]. The third generation of softwares comprises of
pathway topology (PT) based approaches such as the
KEGG [39] and Panther DB [40] that do not only encorpo-
rate individual gene and pathway level statistics computed
by the the ORA and FCS softwares, but they also provide
information about gene products that interact with each
other in a given pathway, how they interact (e.g. activation,
inhibition, etc), and where thay interact (e.g. cytoplasm, nu-
cleus, endoplasmic reticulum, etc). Hence, in this study we
used the KEGG pathway analysis software which is a third
generation PT based software to identify networks of genes
that form the Jak/stat signaling pathway from a de novo as-
sembled transcriptome with the aim to better understand
the modulation of genes expressed by TO cells infected
with SAV3. Consistent with all TP-based softwares, the
KEGG pathways used in this study shows gene level statis-
tical analyses for all DEGs and in terms of pathway level
statistic analysis, our findings show that concurrent treat-
ment of TO-cells with type I IFN together with SAV3 infec-
tion significantly enriched the Jak/stat pathway from a
Qvalue of 5.889E-01 (P-value = 8.07E-01) to 1.136E-06 (P-
value = 8.07E-08). This was supported by upregulation of
several activator and signal transducer genes in the TO-VS-
IFN/SAV3 group compared to the TO-VS-SAV3 group. As
for genes that interact with each other and their interaction
sites, the modulation is complex and below we pinpoint
some of the key areas in the pathway where SAV3 infection
interferes.
Receptor genes that activate Jak/stat signaling
Type I receptor genes generated in response to SAV3 in-
fection and type I IFN treatment were classified into the
γC, gp130 and homodimer receptor families based on re-
ceptor classification used for higher vertebrates [41, 42].
Wang et al. [43] reviewed the γC receptor system for
teleost fish in which they reported of IL-2RB, IL-4RA, IL-
13RA and IL-15RA in salmonids which were also differen-
tially expressed in this study. SAV3 infected cells (TO-VS-
SAV3) had more type I receptor genes downregulated
than type I IFN treated cells (TO-SV-IFN/SAV3) suggest-
ing that SAV3 like other alphaviruses in higher verte-
brates, inhibits the activation of several type I receptor
genes post infection. The type II receptor family generated
in this study was classfied into IL and IFN receptor genes.
As for genes of the IFN receptor genes, IFNR1 and IFNR2
were expressed in both the TO-VS-IFN/SAV3 and TO-VS-
SAV3 suggesting that activation of IFN-α/β receptors oc-
curs as consequence of infection as well as IFN I treatment
(as would be expected). However, it is important to point
out that although our findings show the presence of both
IFNR1 and IFNR2, which is in agreement with observations
made by Ali et al. [44] who reported the presence of both
IFNR1 and IFNR2 based on a transcriptome analysis of
rainbow trout spleen. Studies carried out by Sun et al. [45]
suggest that Atlantic salmon possess two clusters type I
IFN receptor genes located on different chromosomes
which allow for a large repertoire of IFN receptors than
mammals and zebrafish. Hence, there is need for further
studies to compare the IFNR1 and IFNR2 genes detected in
this study with the IFN receptor genes repertoire reported
by Sun et al. [45] and to determine their functional roles in
the Jakstat pathway signaling. The expression of IFNGR1
and IFNGR2 was only found in the TO-VS-IFN/SAV3 cells.
This suggests that SAV3 infection does not activate the
IFNγ-receptors. The importance of IFN-γ in eliciting an
antiviral effect in vitro remains non-conclusive. We have
shown that IFN-γ exhibits marginal antiviral effect against
SAV3 in vitro [16]. In contrast Sun et al. [46] suggested that
recombinant trout IFN-γ had antiviral effect, although they
also concluded that the observed effect of IFN-γ is partly
dependent on IFN-α induction [47]. Additional studies are
needed to understand the importance of IFN-γ in relation
to SAV3 infection.
Janus kinase and tyrosine phosphatase kinase genes
Four Jak-family members have been identified namely
Jak1–Jak3 and Tyk2 in mammalia [48] and fish [49–52]
of which Jak1, Jak2 and Tyk2 transcripts generated in
this study were matched to their mammalian and fish
orthologues. The mechanisms underlying activation,
regulation and pleiotropic signaling in fish have not been
studied in detail. Here we find that Jak1 was upregulated
in SAV3 infected TO cells, with or without IFN-I treat-
ment, while Jak2 and Tyk2 were only differentially
expressed in the TO-VS-SAV3 groups, and importantly,
they were both downregulated. Thus, these findings sug-
gest that SAV3 infection activates Jak1 signaling while it
suppresses activation of Tyk2 and Jak2. These observa-
tions are in line with what is seen for alphavirus infec-
tions in higher vertebrates in which blockage of Tyk2
was shown for Japanese encephalitis virus (JEV) [5],
while Dengue virus type 2 was found to antagonize the
Jak/stat pathway by downregulating Tyk2-stat signaling
in human dendritic cells [53]. Lin et al. [5] showed that
JEV infection blocked tyrosine phosphorylation of IFN
associated Tyk2 without affecting the expression of IFN-
α/β on the cell surface. We found that IFNα was upreg-
ulated when Tyk2 was downregulated, and while it is
possible that SAV3 uses similar mechanisms to what is
seen for other alphaviruses to block the phosphorylation
of Tyk2 thereby inhibiting Jak/stat signaling in TO-cells,
this remains to be shown.
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Signal transducer and activator of transcription genes
Type I IFN mediates tyrosine phosphorylation by binding
to receptors associated with Jak1 and Tyk2 which activates
Stats 1 and 2, while IFNγ mediates its signaling through
Jaks 1 and 2 to activate Stat1 in mammalian cells [27, 42].
The TO-SV-IFN/SAV3 showed upregulation of IFNγ re-
ceptor genes, corresponding to the observed upregulation
of Jak1 and Stat1, while downregulation of Tyk2 in SAV3
infected cells showed a corresponding downregulation of
Stat3 and Stat5. Hence, it is possible that mechanisms in
salmon and human cells are comparable, however, to
identify the different Jaks that activate specific Stats in fish
cells, there is need for detailed investigations.
Studies in higher vertebrates show that alphaviruses
block the Jak/stat signaling pathway by inhibiting the
phosphorylation of different Stats to prevent the tran-
scription of antiviral genes in infected cells. For example,
JEV infections block tyrosine phosporylation of Stats 1,
2 and 3 [46] while CHIKV nsPs were potent inhibitors
of IFN-induced Jak/stat signaling by blocking stat1 phos-
phorylation of the Jak-receptors either by type I or II
IFNs [1]. The observed downregulation of several type I
and II receptor genes in SAV3 infected cells could re-
sulted in inhibition of Jak2 and Tyk2 phosphorylation,
which would align with the downregulation of most Stat
genes. Although these data suggest that SAV3 could be
using mechanisms similar to those used by mammalian
alphaviruses to block the Jak/stat pathway, there is need
for detailed investigations to consolidate these observa-
tions in TO-cells.
Negative regulatory genes
The negative regulatory genes linked to inhibition of the
Jak/STAT pathway include genes that form a negative
feedback loop comprising of members of the SOCS fam-
ily and genes that directly inhibit the Jak/stat pathway
such as PTP1b, SHP and PIAS. In salmonids, several
SOCS genes have been cloned and characterized [53, 54]
and studies carried out by Skjesol et al. [55] show that
SOCS1 supresseses type I and II signaling of the Jak/stat
pathway in Atlantic salmon. In mammalia, SOCS1 and
SOCS3 but not SOCS2 inhibit IFN-mediated antiviral
activities [52]. In this study, SOCS1 was upregulated in
both TO-VS-IFN/SAV3 and TO-VS-SAV3 while SOCS3
was only upregulated in the TO-VS-IFN/SAV3 and
downregulated in the TO-VS-SAV3 suggesting that
SAV3 replication could have suppressed the expression
of SOCS3.
Among the genes that directly inhibit Jak signaling,
only PIAS was differentially expressed and it was upreg-
ulated in the TO-VS-IFN/SAV3 and downregulated in
the TO-VS-SAV3, suggesting that SAV3 suppressed the
expression of PIAS in TO-cells. Although PIAS has not
been characterized in salmonids, its expression at
transcript level in this study suggests that it exists in At-
lantic salmon and that it likely to play an important role
in regulating the Jak/stat pathway in TO-cells. Overall,
these negative regulators were all downregulated in the
TO-VS-SAV3 cells, except for SOCS1, suggesting that
SAV-3 upregulates SOCS1 to prolong its survival in in-
fected cells.
Apoptosis and cell-proliferation genes
Here we find that apoptosis related genes Pim-1, c-Myc
and CycD are upregulated in the TO-VS-IFN/SAV3 and
downregulated in the TO-VS-SAV3 cells. Apoptosis fol-
lowing virus infection is an important defense mecha-
nisms given that cell autodestruction is one of the safest
ways of limiting virus spread to neighboring cells in an in-
fected host [56]. However, viruses have evolved defense
mechanisms that evade or delay apoptosis [56–58] by al-
tering the expression of anti-apoptosis target genes that
regulate cell growth and proliferation [59–62]. Our finding
can be interpreted as a survival strategy of SAV3 to pro-
long its replication cycle in TO-cells. Further, it is also
possible that the expression of PI3K and AKT could be
regulating SAV3 induced apoptosis in TO-cells as shown
for other alphavirus where PI3K-AKT pathway regulates
cell survival by preventing caspase-8 activation to prevent
apoptosis in virus infected cells [63–65]. Mastrangelo et
al. [66, 67] have shown that Bcl-2 and BcI-xL limit apop-
tosis upon infection with alphaviruses while CycD has
been shown to exert the same effects in neuronal cells in-
fected by Sindbis virus [68]. Similarly, Pim-1 acts syner-
gestically with c-Myc [61], to inhibit apoptosis related
mitochondrial dysfunction through the bcl-2 dependent
pathway [62, 69]. It remains to be shown whether down-
regulation of apoptosis target genes in the TO-VS-SAV3
cells could be an evasion strategy to shutdown cell-death
or to slowdown apoptosis to prolong replication time in
infected TO-cells.
Conclusion
This study provides a global overview of genes that form
the Jak/stat pathway induced by SAV3 infection and the
combined IFN I/SAV3 infection allow us to pinpoint
modulating effects of SAV3 infection on the Jak/stat sig-
naling pathway. It is important to note that the data pre-
sented here only provides a repertoire of downregulated
and upregulated genes interlinked in a de novo assembled
network pathway analysis, and does not show the exact
mechanism by which the modulatory processes take place.
Thus a lot of work remains to be done to elucidate the
exact interaction points and modulation of the Jak/stat
encoded proteins. genes generated by de novo assembly in
this study. Further, the study shows that combining de
novo assembly with pathway based analysis increases the
explanatory power of transcriptome data analysis by
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putting together a network of genes that regulate host-
pathogen interaction processes at cellular level. We antici-
pate that the Jak/stat pathway genes put forth in this study
shall serve as a roadmap for elucidating molecular mecha-
nisms used by SAV3 infection to evade host defensins at
cellular level.
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